PanGenomic Health Inc.

Mydecine Innovations Group Inc. (OTC: MYCOF), a biotech company engineering next-gen psychedelic therapeutics, announced that it has closed the sale of all of issued and outstanding shares of its wholly-owned subsidiary, Mindleap Health Inc. to PanGenomic Health Inc., a precision health...